Class of 2022
Scientific Areas of Expertise: Cancer Therapeutics, Gastrointestinal Malignancies, Molecular Diagnostics
For pioneering efforts to provide the first definitive examples of circulating tumor DNA being successfully used as a cancer biomarker for screening, monitoring, and detection of occult disease, and for the discovery of the therapeutic link between immunotherapy and cancer genetics in patients with mismatch repair deficient tumors.